We are live on ! Find out more
NNVC icon

NanoViricides

36 hedge funds and large institutions have $731K invested in NanoViricides in 2019 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 4 increasing their positions, 6 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

0.13% less ownership

Funds ownership: 0.33%0.2% (-0.13%)

8% less funds holding

Funds holding: 3936 (-3)

33% less repeat investments, than reductions

Existing positions increased: 4 | Existing positions reduced: 6

40% less capital invested

Capital invested by funds: $1.23M → $731K (-$495K)

75% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 4

Holders
36
Holders Change
-3
Holders Change %
-7.69%
% of All Funds
0.78%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
1
Increased
4
Reduced
6
Closed
4
Calls
Puts
Net Calls
Net Calls Change

NNVC Hedge Fund Activity: Q2 2019 in Review

36 of the 4,604 institutional investors tracked by Wall St. Rank reported a position in NanoViricides (NNVC) for Q2 2019, worth a combined $731K — down 40% from $1.23M a quarter earlier.

Sellers outnumbered buyers: 4 funds closed out of NNVC and 1 opened new positions — a net loss of 3 holders — while 6 trimmed existing stakes and 4 added.

The largest buyer was Renaissance Technologies, adding an estimated $19.5K. The largest seller was Hudson Bay Capital Management, exiting entirely with an estimated $368K sold.

  • 36 institutional investors held NanoViricides (NNVC) as of Q2 2019, down from 39 in Q1 2019.
  • Funds reported $731K of NanoViricides stock for Q2 2019, down 40% quarter-over-quarter.
  • 1 fund opened new NanoViricides positions in Q2 2019 and 4 closed out, a net change of -3 holders.
  • The largest NanoViricides buyer in Q2 2019 was Renaissance Technologies, an estimated $19.5K added.
  • The largest NanoViricides seller in Q2 2019 was Hudson Bay Capital Management, an estimated $368K sold.

Based on aggregated 13F filings for Q2 2019.